LUCD Lucid Diagnostics Inc.: institutional ownership and insider trading
121 funds reported holding $70.9M of Lucid Diagnostics Inc. in their latest 13F filings; in Q2 2026 funds net bought $28.7M, with 25 new positions and 10 funds selling out; over the last 12 months insiders bought $245K and sold $0 on the open market.
Famous investors holding LUCD
- Renaissance Technologies (Renaissance Technologies): $76.3K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $38.9K, 0.0% of the portfolio
Largest institutional holders of LUCD
- Alyeska Investment Group, L.P. — $9.48M
- BlackRock, Inc. (BLK) — $8.96M
- VANGUARD CAPITAL MANAGEMENT LLC — $7.02M
- VANGUARD GROUP INC — $5.42M
- Two Seas Capital LP — $4.51M
- MASTERS CAPITAL MANAGEMENT LLC — $4.28M
- Aberdeen Group plc — $4.09M
- GEODE CAPITAL MANAGEMENT, LLC — $4.06M
- STATE STREET CORP (STT, STT-PG) — $2.61M
- FIRST MANHATTAN CO. LLC. — $2.34M
Recent LUCD insider trades
- May 20, 2026: Matheis Dennis bought 245,000 shares ($245K)
- Aug 20, 2025: Matheis Dennis bought 100,000 shares ($102K)
- May 22, 2025: Matheis Dennis bought 350,000 shares ($458K)
5%+ owners
- PAVmed Inc.: 27.5% (Schedule 13D/A, filed Feb 9, 2026)